Previous Page  24 / 46 Next Page
Information
Show Menu
Previous Page 24 / 46 Next Page
Page Background

Page 65

Notes:

conferenceseries

.com

Volume 7, Issue 5 (Suppl)

J Clin Trials, an open access journal

ISSN:2167-0870

Clinical Trials 2017

September 11-13, 2017

September 11-13, 2017 San Antonio, USA

4

th

International Conference on

Cl inical Tr ial s

Primary outcome is not significant, now what?

Geraldine E Baggs

Abbott Nutrition Research and Development, USA

R

andomized controlled trials provide a high level of evidence regarding the cause and effect relationship between intervention

and a predefined primary outcome. Adequate well-controlled trials do not come with a low price tag. When the primary

outcome show small non-significant positive trends, what can be done to salvage the trial? While these neutral trials fall short

of providing convincing evidence of efficacy, sponsors are well served in mining the data for potential answers to the following:

Are there any subgroups that may potentially benefit from the intervention?, and are there any posthoc analyses that may help

elucidate the treatment effect? Posthoc analyses may help improve study design and in some cases establish care pathway.

Subgroup analyses are a useful hypotheses generating activity for future trials. Preferably, they have been prespecified in the

study protocol, based on the study primary outcome, found by tests for interactions and based on baseline risk categorization.

We present examples based on the sponsor experience and from the literature.

Biography

Geraldine E Baggs has completed her PhD in Statistics from The Ohio State University. She is currently working as a Section Manager of the Statistical Sciences

Department at Abbott Nutrition R&D. In this role, she provides statistical leadership in the design, monitoring, analysis, and interpretation of clinical trial data,

contributes to regulatory submissions and registration efforts globally, assists legal, QA and food safety groups, and manages the strategic direction of the statistical

sciences group.

geraldine.baggs@abbott.com

Geraldine E Baggs, J Clin Trials 2017, 7:5 (Suppl)

DOI: 10.4172/2167-0870-C1-019